US Broker Ratings

Immutep Limited (IMMP): Biotech Pioneer with a 413% Potential Upside

Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, is making waves in the healthcare sector with its promising pipeline of LAG-3 related immunotherapies. As a late-stage..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a 203% Potential Upside in the Biotech Sector

Heron Therapeutics, Inc. (NASDAQ: HRTX) is capturing investor attention with its substantial 203.40% potential upside, according to analyst ratings. As a player in the biotechnology sector,..

Alpha Tau Medical Ltd. (DRTS): Analyst Consensus and Growth Potential Indicate a Promising 185% Upside

Alpha Tau Medical Ltd. (NASDAQ: DRTS), a Jerusalem-based biotechnology firm, is garnering significant attention with its groundbreaking work in oncology therapeutics. Specializing in diffusing alpha-emitters radiation..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 67% Upside Potential in Medical Devices

Cytek Biosciences, Inc. (NASDAQ: CTKB), a pivotal player in the healthcare sector’s medical devices industry, offers a tantalizing 67.15% potential upside according to analyst ratings. With..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Potential 159% Upside in Biotech Sector

Entrada Therapeutics, Inc. (NASDAQ: TRDA) is making waves in the biotech sector with its innovative approach to treating neuromuscular diseases. With its market cap standing at..

Absci Corporation (ABSI) Stock Analysis: A Biotechnology Innovator with Over 200% Potential Upside

Absci Corporation (NASDAQ: ABSI), a pioneering entity in the biotechnology sector, is drawing considerable attention from investors, primarily due to its robust potential for upside. With..

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Revenue Challenges and Market Positioning

Anbio Biotechnology (NNNN), a promising player in the healthcare sector, specializes in medical instruments and supplies, with a focus on in vitro diagnostics (IVD) products. Based..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Eye-Catching 59% Potential Upside for Biotech Investors

Investors with an appetite for risk-reward scenarios in the biotech sector might want to take a closer look at Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL). With a..

The Pennant Group, Inc. (PNTG) Investor Outlook: Exploring a 16.55% Potential Upside in Healthcare Services

The Pennant Group, Inc. (NASDAQ: PNTG) has emerged as a noteworthy player in the healthcare sector, specializing in medical care facilities across the United States. With..

Evolent Health, Inc (EVH) Stock Analysis: A Potential 77.79% Upside with Strong Buy Ratings

Evolent Health, Inc. (NASDAQ: EVH) stands out in the healthcare sector, particularly within the health information services industry, as an intriguing investment opportunity. With a market..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Strong Buy Ratings and a 31% Upside Potential

BioLife Solutions, Inc. (BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.13 billion,..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a Promising 22.85% Upside Potential

For investors eyeing opportunities in the biotechnology sector, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) presents an intriguing case. With a current market capitalization of $1.1 billion, this..

Mesoblast Limited (MESO) Stock Analysis: A Biotech with 127.85% Potential Upside

Mesoblast Limited (NASDAQ: MESO), an innovative player in the biotechnology sector, is capturing investor attention with a significant potential upside of 127.85%, according to recent analyst..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: 37.7% Potential Upside Beckons Investors

Establishment Labs Holdings Inc (NASDAQ: ESTA), a pioneering medical technology company in the healthcare sector, is making waves with its innovative solutions in the aesthetic and..

Biohaven Ltd. (BHVN) Investor Outlook: Potential 222.65% Upside Amid Promising Clinical Trials

Biohaven Ltd. (NYSE: BHVN) presents a compelling case for investors intrigued by the biotechnology sector, with its substantial potential upside of 222.65% based on current analyst..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 25% Potential Upside in the Healthcare Sector

Investors looking for promising opportunities in the healthcare sector might find LeMaitre Vascular, Inc. (NASDAQ: LMAT) an intriguing option. This Burlington, Massachusetts-based company, a prominent player..

CONMED Corporation (CNMD) Stock Analysis: Exploring an 11.22% Potential Upside in the Medical Device Sector

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector specializing in medical devices, offers an intriguing investment opportunity for those looking to capitalize on..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: 48.79% Potential Upside Fuels Investor Interest

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of dermatological treatments. Founded..

Aveanna Healthcare Holdings Inc (AVAH) Stock Report: Evaluating the 10.34% Potential Upside for Investors

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) stands as a unique player in the U.S. healthcare sector, specifically within the Medical Care Facilities industry. As a diversified..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Strategizing for a 117% Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents an intriguing opportunity for investors, especially given the substantial potential upside of 117.48% indicated by analyst targets. As a player..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds